Wilmer Cutler Pickering Hale and Dorr represented Air Space Intelligence in the transaction. Air Space Intelligence (ASI) announced the completion of a $34 million Series B funding round....
Air Space Intelligence’s$34 Million Series B Financing Round
Voyager Therapeutics’ Collaboration Agreement with Neurocrine Biosciences
Wilmer Cutler Pickering Hale and Dorr advised Voyager Therapeutics on the deal. Voyager Therapeutics announced that it entered into a strategic collaboration agreement with Neurocrine Biosciences...
Swvl Holding’s Acquisition of Urbvan Mobility Spa
Pérez Correa González advised Swvl Holding Corp. on the deal. WilmerHale and Ritch Mueller advised Urbvan Mobility Spa. Nasdaq-listed transportation startup Swvl Holdings Corp. executed the...
Voyager Therapeutics’ License Option Agreement with Novartis
WilmerHale advised Voyager Therapeutics on the deal. Voyager Therapeutics, a gene therapy company developing life-changing treatments and next-generation adeno-associated virus (AAV) capsids, announced it entered into...
BandLab’s $53 Million Series B Financing
Wilmer Cutler Pickering Hale and Dorr advised BandLab on the deal. BandLab, the Singapore-based social music platform bringing pro-quality creator tools to music makers worldwide, announced its...
Apellis’ Research Collaboration With Beam Therapeutics
Wilmer Cutler Pickering Hale and Dorr advised Apellis Pharmaceuticals on the deal. Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Beam Therapeutics Inc. (Nasdaq: BEAM), announced that they...
Cue Health Inc.’s $235 Million Private Financing Round
Wilmer Cutler Pickering Hale and Dorr advised Cue Health Inc. on the deal. Cue Health Inc., a health technology company, announced the closing of its $235...